Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia.
Comments Off on Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia.
April 28, 2026
The relationship between the endocannabinoid system and the emergence and treatment of schizophrenia-related symptoms continues to be a topic of significant ...
Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis.
Comments Off on Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis.
April 27, 2026
This study examines the association cannabis use disorder psychiatric conditions compared to other substance use disorders. Researchers used a propensity-matched retrospective cohort analysis. The findings highlight differences in mental disorder risks…
Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia
Comments Off on Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia
April 17, 2026
The study of cb1 receptor biased signaling schizophrenia reveals new therapeutic possibilities. This research highlights how selective modulation of CB1 receptors may benefit schizophrenia treatment. Understanding this mechanism is crucial for advancing…